Literature DB >> 7217336

Separation of immunoglobulin M (IgM) essentially free of IgG from serum for use in systems requiring assay of IgM-type antibodies without interference from rheumatoid factor.

R B Johnson, R Libby.   

Abstract

The proposed method was designed to replace the tedious and difficult separation of immunoglobulin M (IgM) from IgG by sucrose gradient sedimentation. In this method, a 250-microliter portion of serum diluted 20-fold was passed through a small column of quaternary aminoethyl-Sephadex A-50 ion exchanger. IgG was not retained, but additional washes were required to remove all but 5%. A second buffer-eluting fluid recovered an average of 80% of the original IgM in a defined dilution. The entire operation took 15 min. The efficiency of this process was evaluated by the following: (i) radial immunodiffusion measurements of IgG and IgM; (ii) recovery studies of isohemagglutinins; and (iii) demonstrated removal of interference by the rheumatoid factor. The method was applied successfully to distinguish rubella IgM antibody.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7217336      PMCID: PMC273607          DOI: 10.1128/jcm.12.3.451-454.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  An indirect immunofluorescent antibody test for determination of Rubella virus specific IgM antibodies. Elimination of secondary IgM rheumatoid factor staining after absorption of serum IgG with Staphylococcal protein A.

Authors:  K Skaug; P I Gaarder
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-02

2.  A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus.

Authors:  J Ankerst; P Christensen; L Kjellén; G Kronvall
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

3.  Glutaraldehyde-activated aminohexyl- derivative of Sepharose 4B as a new verstile immunoabsorbent.

Authors:  C L Cambiaso; A Goffinet; J P Vaerman; J F Heremans
Journal:  Immunochemistry       Date:  1975-04

4.  Enzyme-linked immunosorbent assays for cholera serology.

Authors:  J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

5.  Congenital rubella. Clinicopathologic, virologic, and immunologic studies.

Authors:  J A Bellanti; M S Artenstein; L C Olson; E L Buescher; C E Luhrs; K L Milstead
Journal:  Am J Dis Child       Date:  1965-10

6.  A 30-minute preparative method for isolation of IgG from human serum.

Authors:  A J Webb
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

7.  A serological method for demonstrating recent infection by rubella virus.

Authors:  J E Banatvala; J M Best; E A Kennedy; E E Smith; M E Spence
Journal:  Br Med J       Date:  1967-07-29

8.  Evaluation of a simplified sucrose gradient method for the detection of rubella-specific IgM in routine diagnostic practice.

Authors:  E O Caul; S J Hobbs; P C Roberts; S K Clarke
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

9.  Single-sample diagnosis of recent rubella by fractionation of antibody on Sephadex G-200 column.

Authors:  J D Gupta; V Peterson; M Stout; A M Murphy
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

10.  IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies.

Authors:  O H Meurman; B R Ziola
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

View more
  15 in total

1.  Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus.

Authors:  S J Wu; B Hanson; H Paxton; A Nisalak; D W Vaughn; C Rossi; E A Henchal; K R Porter; D M Watts; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.

Authors:  P A Shurin; G S Giebink; D L Wegman; D Ambrosino; J Rholl; M Overman; T Bauer; G R Siber
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

4.  The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.

Authors:  N Falser
Journal:  Arch Otorhinolaryngol       Date:  1984

5.  Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus.

Authors:  J M Meegan; B K Evans; D M Horstmann
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

6.  Serological diagnosis of Toxoplasma gondii infections by rapid separation of serum immunoglobulins M and G with CM Bio-Gel A.

Authors:  G A Ordonez; J T Newman; M J Stone
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

7.  Cross-sectional study of reverse transcriptase-inhibiting antibody as a marker of acquired immune deficiency syndrome.

Authors:  M Advani; D T Imagawa; M H Lee; K Sano; F Morales; R T Mitsuyasu; R Detels
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

8.  Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer.

Authors:  J Rosenecker; K H Harms; R M Bertele; A Pohl-Koppe; E v Mutius; D Adam; T Nicolai
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

9.  Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis.

Authors:  M G Peacock; R N Philip; J C Williams; R S Faulkner
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Relative functional activity of purified human immunoglobulin G against a type III group B streptococcal strain.

Authors:  K S Kim; J H Kang; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.